TargED

TargED Biopharmaceuticals

The company develops targeted biological drugs to treat thrombotic diseases such as acute ischaemic stroke and immune-mediated thrombotic thrombocytopenic purpura for healthcare providers.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

VarmX

This biotech company develops recombinant blood clotting factors to treat patients with severe bleeding or requiring urgent surgery while taking oral anticoagulants.

TargeGen

This company develops small molecule kinase inhibitors to treat blood disorders and inflammatory diseases for patients with unmet medical needs.

THROMBECTOMY SYSTEMS

This company develops catheter-based clot removal systems for physicians treating patients with venous thromboembolism, deep vein thrombosis and pulmonary embolism.

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

Theraport

Theraport develops engineered exosomes to facilitate the targeted delivery of drugs and genetic medicines for patients with complex diseases.

Aptatargets

The company develops aptamer-based therapeutic drugs for patients with acute ischemic stroke and other inflammatory or cardiovascular diseases.